Since RBM4 was highly expressed in tumor and pre-cancerous lesions compared to normal tissues and exhibited oncogenic activity in ESCC as showed in Fig. 1a–f and Supplementary Fig. 1, we next define whether RBM4 might play a role in promoting senescence bypass during ESCC progression. Here, RBM4 is linked to neoplasm.